A step ahead: Exploring the gut microbiota in inpatients with bipolar disorder during a depressive episodeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
Researchers analyzed gut microbiota composition in hospitalized adults with bipolar disorder during a depressive episode. They examined its relation to inflammation, serum lipids, oxidative stress, tryptophan/kynurenine levels and metabolic syndrome, and compared microbial community differences against healthy controls.
How was it studied?
This cross-sectional study performed 16S rRNA gene sequencing on stool samples from 32 inpatients with bipolar I disorder (14 female, mean age 41.3) and 10 healthy controls. Microbial community analysis and correlations with clinical parameters used QIIME, with LEfSe for differential taxon abundance.
What did they find?
Microbial alpha-diversity correlated negatively with illness duration in bipolar patients (R = -0.408, P = 0.021). LEfSe identified the phylum Actinobacteria and class Coriobacteria as significantly more abundant in bipolar disorder than controls, while Ruminococcaceae and Faecalibacterium were more abundant in controls. Distinct bacterial clades were also linked to inflammatory markers, lipids, tryptophan levels, oxidative stress and metabolic syndrome parameters within the bipolar group.
Why it matters
The findings suggest causes or consequences of bipolar disorder may lie outside the brain, implicating the gut-brain axis. The authors propose gut microbiota research could reveal new underlying mechanisms and therapeutic targets for mood disorders like bipolar disorder.